<DOC>
	<DOCNO>NCT00471614</DOCNO>
	<brief_summary>The purpose study determine whether uridine supplementation improve insulin sensitivity overall carbohydrate metabolism HIV-positive subject currently undergo treatment antiretroviral regimen contain stavudine zidovudine evidence impair mitochondrial function insulin resistance .</brief_summary>
	<brief_title>Effects Uridine Supplementation Metabolic Side Effects Stavudine Zidovudine</brief_title>
	<detailed_description>Treatment HIV infection nucleoside analogue reverse transcriptase inhibitor ( NRTIs ) associate numerous toxicity attribute impaired mitochondrial function secondary reduction level mitochondrial DNA ( mtDNA ) . Abnormalities mitochondrial function implicate development insulin resistance patient HIV infection also hypothesize underlie many pathophysiologic feature type 2 diabetes mellitus non-HIV infected individual . Uridine , pyrimidine nucleoside play essential role synthesis RNA key physiologic process , propose therapy NRTI-induced mitochondrial dysfunction . Uridine supplementation protect bone marrow cell toxicity zidovudine , normalized growth neuron expose NRTIs , abrogate mitochondrial toxicity NRTIs HepG2 cell vitro . A food supplement call NucleomaxX速 , extract stem sugar cane , raise plasma uridine concentration level know prevent mitochondrial toxicity vitro . In recent case report , oral administration uridine , give form NucleomaxX速 , ameliorate mitochondrial toxicity cause stavudine lead improvement myalgia liver muscle enzyme , despite continue treatment stavudine . In clinical study 14 HIV-infected patient treat stavudine zidovudine , NucleomaxX速 lead improve hepatic mitochondrial function assess 13C-methionine breath test . We perform randomize double-blind placebo-controlled study 20 HIV-positive subject currently undergo treatment antiretroviral regimen contain stavudine zidovudine evidence impair mitochondrial function insulin resistance . Subjects hospitalize SFGH CTSI Clinical Research Center ( CCRC ) 6 day undergo comprehensive metabolic study . Subjects randomize , 1:1 fashion , receive either NucleomaxX速 placebo two month , repeat 6-day CCRC-based assessment . This study design test hypothesis , comparison placebo , uridine supplementation enhance mitochondrial function , associate concomitant improvement glucose lipid metabolism .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperlactatemia</mesh_term>
	<criteria>Confirmed HIV1 infection HIV1 RNA &lt; 10,000 copies/mL within 30 day study entry Treatment stavudine zidovudine least 12 month prior entry plan discontinue duration study Stable antiretroviral regimen least 3 month prior entry plan change antiretroviral therapy duration study Mitochondrial dysfunction evidence fast plasma lactate level &gt; 1.5 mmol/L Insulin resistance evidence HOMAIR &gt; 2.77 calculate fast blood sample ( glucose insulin ) obtain screen visit Karnofsky performance score &gt; = 80 Women stable regimen hormonal contraceptive hormone replacement therapy least 6 month prior enrollment may participate Men stable dos testosterone replacement therapy 6 month prior enrollment may participate Subjects stable dose lipid lower agent 6 month prior enrollment may participate Serum creatinine blood urea nitrogen &gt; 1.5 upper limit normal ( ULN ) Direct bilirubin &gt; 2 X ULN AST ( SGOT ) ALT ( SGPT ) &gt; 5 x ULN Hgb &lt; 8.5 g/dL Abnormal hepatitis B C serology A clinical diagnosis diabetes mellitus fast glucose &gt; 126 mg/dl Physical functional obstruction food intake impaired absorption A clinically suspect concomitant treatable infection yet treat An opportunistic infection within precede 30 day Ascites Pregnancy Treatment growth hormone , anabolic steroid ( include supraphysiologic dos testosterone ) , glucocorticoid , insulin , sulfonylurea , metformin , thiazolidinediones , appetite stimulant within precede 6 month Dementia , active drug alcohol abuse dependence , condition would preclude adherence protocol ability provide inform consent . Any condition , opinion investigator , would put subject risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>uridine</keyword>
	<keyword>mitochondrion</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>